Trial Profile
A Phase 3 Multicentre, Randomised, Comparative Study of the Efficacy and Safety of the Ultrasound Contrast Agents Sonazoid™ and SonoVue® in Subjects With Focal Liver Lesions Undergoing Pre- and Post-Contrast Ultrasound Imaging
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Nov 2018
Price :
$35
*
At a glance
- Drugs Perflubutane (Primary) ; Sulfur hexafluoride (Primary)
- Indications Hepatic lesion
- Focus Diagnostic use
- 10 Nov 2017 New trial record